His current research is to apply stem cell technology to disease modeling and therapeutic applications for neuromuscular diseases. He has engaged in basic and translational studies using human neural progenitor cells, mesenchymal stem cells, and pluripotent stem cells to develop therapeutic strategies for amyotrophic lateral sclerosis (ALS), muscular dystrophy, and Pompe disease (glycogen storage disease type II).